MediPharm Labs Corp. (TSE:LABS – Get Free Report) hit a new 52-week low on Monday. The company traded as low as C$0.06 and last traded at C$0.07, with a volume of 10,591 shares traded. The stock had previously closed at C$0.07.
MediPharm Labs Stock Performance
The stock has a market capitalization of C$25.63 million, a P/E ratio of -6.00 and a beta of -0.60. The company has a quick ratio of 3.10, a current ratio of 2.66 and a debt-to-equity ratio of 0.90. The business has a fifty day moving average price of C$0.07 and a 200-day moving average price of C$0.07.
MediPharm Labs Company Profile
Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API), and advanced derivative products produced in a GMP-certified facility with ISO-standard clean rooms. MediPharm has invested in an expert research-driven team, state-of-the-art technology, advanced purification methodologies, and purpose-built facilities to deliver pure, trusted, precision-dosed cannabinoid products for domestic and international markets.
Recommended Stories
- Five stocks we like better than MediPharm Labs
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
